Geriatric Medication Safety Symposium
老年用药安全研讨会
基本信息
- 批准号:10456818
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdministratorAdverse drug eventAgingAreaBedsCOVID-19 pandemicCaringChronicClinicCollaborationsComplexDental SchoolsDevelopmentDiseaseDrug InteractionsDrug PrescriptionsDrug usageEducational TechnologyEducational workshopElderlyEventFundingGoalsGrantHealthHealth ExpendituresHealth OccupationsHealth ProfessionalHealthcareHospitalizationHospitalsIncidenceInstitutionJointsJournalsKnowledgeLeadMedicalMedical Care CostsMedical centerMedication ErrorsMonitorMorbidity - disease rateNamesNursesNursing SchoolsOnline SystemsPatient CarePatientsPeer ReviewPersonsPharmaceutical PreparationsPharmacistsPharmacy SchoolsPharmacy facilityPhysiciansPoliciesPolypharmacyPreventionProcessProviderPublicationsPublishingResearchResearch PersonnelRiskScientistSeasonsStudentsTexasTreatment FailureUniversitiesage relatedbody systemcollegeevidence baseexperiencehigh riskhospital readmissionimprovedinpatient servicelive streammedical schoolsmedication safetymeetingsmembermortalityoff-label drugopioid abuseopioid useoutreachpatient safetypharmacokinetics and pharmacodynamicsposterssocialsymposiumtoolvirtualwebinar
项目摘要
ABSTRACT
Medication-related morbidity and mortality are a significant health concern in older adults, who are highly
susceptible to medication-related problems. Safe medication use practices require coordinated efforts by
providers and patients in the medication use process. Medication-related problems in older adults range from
prescribing of high-risk medications to misuse of prescribed medications by older adults. Reducing medication
errors and improving medication safety are major national priorities. Therefore, our objective is to host the
Geriatric Medication Safety Symposium in the largest medical complex in the world, the Texas Medical Center
(TMC), annually to disseminate and implement the evidence-based approaches for medication safety in older
adults to improve the quality of geriatric care. The University of Houston College of Pharmacy in collaboration
with the University of Texas McGovern Medical School organized the Houston Medication Safety Symposium
for the past three years focusing on various aspects of medication safety issues such high-risk medications,
prescribing cascades, and deprescribing with presentations from nationally recognized experts. An average of
151 diverse health professions participated in the symposium each year to enrich their practice and research on
medication safety. In addition, the symposium included research podiums and posters that were published in a
peer-reviewed journal. We are requesting five years of funding to host the Geriatric Medication Safety
Symposium to continue our successful efforts to disseminate critical medication safety issues with respect to
practice, research, and policy. This annual symposium will: (i) Provide an excellent interprofessional educational
forum for practitioners and researchers to discuss evidence-based medication safety approaches in older adults;
(ii) Increase collaborations for best practices in patient care and medication safety research; and (iii) Disseminate
the knowledge and findings from the symposium nationally through webinars and publications. The proposal
includes monthly planning committee meetings from representatives of selected TMC institutions to plan and
organize the two-day symposium in the TMC, with a reach of over 20,000 healthcare professionals. The
symposium includes four plenary sessions, podium and poster sessions, and practice/research workshops, with
web-based content delivery and integration of virtual content over five years to allow for greater reach. The
areas of focus for the upcoming symposiums include off-label drug use during the COVID-19 pandemic, drug
burden, safer opioid use, adverse drug events, significant drug interactions, drug safety during transitions of
care, and medication safety in inpatient care. The target audience includes physicians, nurses, pharmacists,
students, residents, fellows, researchers, and others. Educational and media tools will be created in addition to
publishing the proceedings in the Research in Social and Administrative Pharmacy journal. Overall, the Geriatric
Medication Safety Symposium will provide a unique interprofessional educational and research forum for
practitioners and researchers to make medication practices safer for older adults in the TMC and beyond.
抽象的
与药物相关的发病率和死亡率是老年人的一个重要健康问题,他们高度关注
容易受到药物相关问题的影响。安全用药实践需要各方的协调努力
药物使用过程中的提供者和患者。老年人与药物相关的问题包括
开出高风险药物以防止老年人滥用处方药物。减少用药
错误和改善用药安全是国家的主要优先事项。因此,我们的目标是举办
老年用药安全研讨会在世界上最大的医疗中心德克萨斯医学中心举行
(TMC),每年传播和实施老年人用药安全的循证方法
成人提高老年护理质量。与休斯敦大学药学院合作
与德克萨斯大学麦戈文医学院合作举办休斯顿用药安全研讨会
过去三年专注于药物安全问题的各个方面,例如高风险药物,
级联处方,并通过国家认可专家的演示进行取消处方。平均
每年有 151 名不同的卫生专业人士参加研讨会,以丰富他们的实践和研究
用药安全。此外,研讨会还设有研究讲台和海报,这些讲台和海报发表在
同行评审期刊。我们请求五年的资金来举办老年用药安全会议
研讨会将继续我们成功传播有关药物安全问题的成功努力
实践、研究和政策。本次年度研讨会将: (i) 提供优秀的跨专业教育
供从业者和研究人员讨论老年人循证用药安全方法的论坛;
(ii) 加强患者护理和药物安全研究最佳实践方面的合作; (iii) 传播
通过网络研讨会和出版物获得全国研讨会的知识和研究结果。提案
包括由选定的 TMC 机构代表召开的每月计划委员会会议,以制定计划和
在 TMC 组织为期两天的研讨会,覆盖 20,000 多名医疗保健专业人员。这
研讨会包括四场全体会议、讲台和海报会议以及实践/研究研讨会,
五年内基于网络的内容交付和虚拟内容集成,以实现更大的覆盖范围。这
即将举行的研讨会的重点领域包括 COVID-19 大流行期间的超说明书用药、药物
负担、更安全的阿片类药物使用、药物不良事件、显着的药物相互作用、过渡期间的药物安全性
住院护理中的护理和用药安全。目标受众包括医生、护士、药剂师、
学生、居民、研究员、研究人员和其他人。除了以下内容之外,还将创建教育和媒体工具
在《社会和行政药学研究》杂志上发表论文集。总体而言,老年病
药物安全研讨会将为患者提供一个独特的跨专业教育和研究论坛
从业人员和研究人员致力于使 TMC 及其他地区的老年人的用药实践更加安全。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rajender R Aparasu其他文献
Rajender R Aparasu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rajender R Aparasu', 18)}}的其他基金
Deprescribing of Disease Modifying Agents in Older Adults with Multiple Sclerosis
患有多发性硬化症的老年人中取消疾病调节剂的处方
- 批准号:
10718559 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Oral Adherence Trajectories Of Disease Modifying Agents And Associated Relapse Rates Among Patients With Multiple Sclerosis
多发性硬化症患者疾病调节剂的口服依从轨迹和相关复发率
- 批准号:
10287874 - 财政年份:2021
- 资助金额:
$ 5万 - 项目类别:
Oral Adherence Trajectories Of Disease Modifying Agents And Associated Relapse Rates Among Patients With Multiple Sclerosis
多发性硬化症患者疾病调节剂的口服依从轨迹和相关复发率
- 批准号:
10434699 - 财政年份:2021
- 资助金额:
$ 5万 - 项目类别:
Impact of Prescribing Cascade and Associated Drug Interaction in Alzheimer's Disease
级联处方和相关药物相互作用对阿尔茨海默病的影响
- 批准号:
10212709 - 财政年份:2020
- 资助金额:
$ 5万 - 项目类别:
Anticholinergics and Cognitive Decline in the Elderly with Depression
抗胆碱能药物与老年抑郁症患者的认知能力下降
- 批准号:
8544461 - 财政年份:2012
- 资助金额:
$ 5万 - 项目类别:
Anticholinergics and Cognitive Decline in the Elderly with Depression
抗胆碱能药物与老年抑郁症患者的认知能力下降
- 批准号:
8708817 - 财政年份:2012
- 资助金额:
$ 5万 - 项目类别:
Anticholinergics and Cognitive Decline in the Elderly with Depression
抗胆碱能药物与老年抑郁症患者的认知能力下降
- 批准号:
8439123 - 财政年份:2012
- 资助金额:
$ 5万 - 项目类别:
Impact of Atypical Antipsychotic Use on Health Care Utilization in the Elderly
非典型抗精神病药物使用对老年人医疗保健利用的影响
- 批准号:
7661416 - 财政年份:2009
- 资助金额:
$ 5万 - 项目类别:
相似国自然基金
基于药品不良事件呈报系统的药靶蛋白预测方法研究
- 批准号:31371344
- 批准年份:2013
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
GAPcare: The Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department
GAPcare:老年急性病
- 批准号:
9364690 - 财政年份:2017
- 资助金额:
$ 5万 - 项目类别: